With CPhI Korea and Milan postponed for 2020. What’s next?

Following the cancellation of 2020 events worldwide, the recent announcements for CPhI events should come as no surprise. Undeterred, organizers are taking bold & creative initiatives to bring people together.

Following talks with stakeholders across the Pharma industry event organizer Informa announced that it wouldn’t be practical to go ahead as planned, and has decided to transform the world’s largest pharma exhibition into a digital event: The CPhI ‘Festival of Pharma’.

Running from 5-16th October, Adam Andersen, Group Director of Pharma at Informa Markets says: “This large-scale digital exhibition will mirror on-site offerings and provide our community with a powerful platform to access vital one-to-one client meetings”.

“This community is resilient.. and we feel compelled to (provide) new and alternative ways to foster connections, discover new partners and help lead the global response and recovery” added Anderson.

QUINTA-ANALYTICA are thrilled to digitally ‘meet’ colleagues from the industry, highlight the world-leading projects we’ve been working on, and of course, to make new connections!

What do you think about the increasing digitization of events? Do you plan to virtually attend any this year?

Additional News

  • 3 September 2026

    Quinta-Analytica Expands HPLC Fleet to Strengthen Flexibility and Capacity for Clients

    New Thermo Scientific Vanquish Core joins an HPLC fleet of around 50 systems

  • 7 August 2026

    Quinta-Analytica at CPHI Milan 2026 – Meet Us at Conscio Group Stand 6N25

    Meet Quinta-Analytica at CPHI Milan 2026 as part of the Conscio Group team at Stand 6N25. Discuss your clinical, bioanalytical and analytical projects with our experts and arrange a meeting in advance.

  • 15 July 2026

    Quinta-Analytica Awarded the EcoVadis Gold Medal

    Quinta-Analytica has been awarded the EcoVadis Gold Medal after achieving an overall sustainability score of 84 out of 100. The result represents a substantial increase from 68 points in the previous assessment and places the company in the 97th percentile globally.